Verfahren zum Screening auf Peptide unter Verwendung mehrerer Bibliotheken
Anmelder: Chugai Seiyaku Kabushiki Kaisha 🇯🇵
Details
- Veröffentlichungs-Nr.
- EP4768598
- Anmeldetag
- 10. Oktober 2024
- Veröffentlichung
- 17. April 2025
- Rechtsraum
- EP
- IPC
- C12Q1/6844, C40B40/02
Abstract
The present invention provides a method for screening for a candidate peptide capable of binding to a target molecule, the method including the steps of: (1) preparing a plurality of nucleic acid display libraries containing a barcoded peptide-nucleic acid complex, wherein the barcoded peptide-nucleic acid complex contains a nucleic acid moiety and a peptide moiety, the nucleic acid moiety contains a barcode sequence and a nucleic acid sequence encoding the peptide, and the plurality of nucleic acid display libraries are nucleic acid display libraries, each of which is independently produced by translation using a cell-free translation system; (2) mixing the plurality of nucleic acid display libraries to prepare a mixed nucleic acid display library; (3) bringing the mixed nucleic acid display library into contact with the target molecule; and (4) amplifying a nucleic acid corresponding to the nucleic acid moiety of the barcoded peptide-nucleic acid complex bound to the target molecule, using a barcode primer.
Anmelder
- Firma
- Chugai Seiyaku Kabushiki Kaisha
- Land
- 🇯🇵 Japan
Chugai Pharmaceutical Co., Ltd. ist ein japanisches Pharmaunternehmen mit Sitz in Tokio, das insbesondere Biopharmazeutika entwickelt und mehrheitlich zur Roche-Gruppe gehört.
398 Patente in unserer Datenbank